decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / PROTHROMBIN_TIME
Subscribe or sign in to view the full article.
Article Overview
This page covers National Coverage Determinations Manual guidance for prothrombin time testing, including when the test may be used, general patient categories associated with medical necessity, and limits on repeat testing or related payment considerations. It is relevant to laboratory coding, compliance, and reimbursement teams who need to understand coverage scope for coagulation testing under Medicare policy.
Why This Topic Matters
Coverage policies for laboratory coagulation testing affect whether claims are payable, how often testing may be supported, and how documentation should align with medical necessity. Understanding this guidance helps coding and billing staff evaluate whether PT-related testing falls within covered indications and limits.
Article Sections
-
Prothrombin Time
Introduces the laboratory test and describes its general role in coagulation assessment and related monitoring context.
-
Indications
Lists the broad clinical circumstances in which the test may be considered for coverage, including medication monitoring, bleeding or clotting concerns, and other related patient conditions.
-
Limitations
Summarizes the main coverage limitations for repeat testing, documentation expectations, and related billing considerations.
What You Will Learn
- The general Medicare coverage context for prothrombin time testing
- The broad categories of clinical circumstances addressed by the policy
- The article’s discussion of testing frequency and repeat-testing limitations
- How the policy treats related reporting and payment considerations
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Revenue cycle teams
- Laboratory professionals
- Healthcare administrators
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com